|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 12702153.3 (espacenet) (Federated) (European Patent Register), 20120126 | | Patent/reg. no. and date | DK/EP 2667892, 20190327 | | Publication date | 20131204 | | Priority no. and date | US 201161436355 P, 20110126 | | EP pub. no. and date |
EP 2667892 20131204 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals SA, Rue de l'Institut 89
1330 Rixensart, BE | | Applicant ref. no. | 162439 | | Inventor | DORMITZER, Philip, R., c/o Novartis Vaccines and Diagnostics Inc.
P.O. Box 8097
Emeryville, CA 94662-8097, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/155 (2006.01) , A61P 31/14 (2006.01) | | Title | RSV-vaccineringsprogram | | Int. application no. | US2012022762 | | Int. publication no. | WO2012103361 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
